Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy

Keisho Chin; Ken Kato; Byoung Chul Cho; Masanobu Takahashi; Morihito Okada; Chen-Yuan Lin; Shigenori Kadowaki; Myung-Ju Ahn; Yasuo Hamamoto; Yuichiro Doki; Chueh-Chuan Yen; Yutaro Kubota; Sung-Bae Kim; Chih-Hung Hsu; Eva Holtved; Ioannis Xynos; Yasuhiro Matsumura; Akira Takazawa; Yuko Kitagawa

Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy

Keisho Chin, Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, Chueh-Chuan Yen, Yutaro Kubota, Sung-Bae Kim, Chih-Hung Hsu, Eva Holtved, Ioannis Xynos, Yasuhiro Matsumura, Akira Takazawa, Yuko Kitagawa

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Clinical Oncology
Vol/bind	39
Udgave nummer	Suppl. 3
Sider (fra-til)	204-204
Antal sider	1
ISSN	0732-183X
Status	Udgivet - 20. jan. 2021
Begivenhed	2021 Gastrointestinal Cancers Symposium - Varighed: 14. jan. 2021 → 16. jan. 2021

Konference

Konference	2021 Gastrointestinal Cancers Symposium
Periode	14/01/2021 → 16/01/2021

Dokumenter og links

https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.3_suppl.204

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Chin, K., Kato, K., Cho, B. C., Takahashi, M., Okada, M., Lin, C.-Y., Kadowaki, S., Ahn, M.-J., Hamamoto, Y., Doki, Y., Yen, C.-C., Kubota, Y., Kim, S.-B., Hsu, C.-H., Holtved, E., Xynos, I., Matsumura, Y., Takazawa, A., & Kitagawa, Y. (2021). Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy. Journal of Clinical Oncology, 39(Suppl. 3), 204-204. https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.3_suppl.204

@article{154ce1d52ee2461eb5cc3c172f7ebb41,

title = "Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy",

author = "Keisho Chin and Ken Kato and Cho, {Byoung Chul} and Masanobu Takahashi and Morihito Okada and Chen-Yuan Lin and Shigenori Kadowaki and Myung-Ju Ahn and Yasuo Hamamoto and Yuichiro Doki and Chueh-Chuan Yen and Yutaro Kubota and Sung-Bae Kim and Chih-Hung Hsu and Eva Holtved and Ioannis Xynos and Yasuhiro Matsumura and Akira Takazawa and Yuko Kitagawa",

year = "2021",

month = jan,

day = "20",

language = "English",

volume = "39",

pages = "204--204",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "Suppl. 3",

note = " 2021 Gastrointestinal Cancers Symposium ; Conference date: 14-01-2021 Through 16-01-2021",

}

Chin, K, Kato, K, Cho, BC, Takahashi, M, Okada, M, Lin, C-Y, Kadowaki, S, Ahn, M-J, Hamamoto, Y, Doki, Y, Yen, C-C, Kubota, Y, Kim, S-B, Hsu, C-H, Holtved, E, Xynos, I, Matsumura, Y, Takazawa, A & Kitagawa, Y 2021, 'Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy', Journal of Clinical Oncology, bind 39, nr. Suppl. 3, s. 204-204. <https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.3_suppl.204>

Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy. / Chin, Keisho; Kato, Ken; Cho, Byoung Chul et al.
I: Journal of Clinical Oncology, Bind 39, Nr. Suppl. 3, 20.01.2021, s. 204-204.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy

AU - Chin, Keisho

AU - Kato, Ken

AU - Cho, Byoung Chul

AU - Takahashi, Masanobu

AU - Okada, Morihito

AU - Lin, Chen-Yuan

AU - Kadowaki, Shigenori

AU - Ahn, Myung-Ju

AU - Hamamoto, Yasuo

AU - Doki, Yuichiro

AU - Yen, Chueh-Chuan

AU - Kubota, Yutaro

AU - Kim, Sung-Bae

AU - Hsu, Chih-Hung

AU - Holtved, Eva

AU - Xynos, Ioannis

AU - Matsumura, Yasuhiro

AU - Takazawa, Akira

AU - Kitagawa, Yuko

PY - 2021/1/20

Y1 - 2021/1/20

M3 - Conference abstract in journal

SN - 0732-183X

VL - 39

SP - 204

EP - 204

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - Suppl. 3

T2 - 2021 Gastrointestinal Cancers Symposium

Y2 - 14 January 2021 through 16 January 2021

ER -